Tamalet C - Search Results

1

National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation.

Delaugerre C, Flandre P, Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Schneider V, Yerly S, LeGoff J, Morand-Joubert L, Chaix ML, Costagliola D, Calvez V; NARS AC11 Resistance Group. Delaugerre C, et al. Among authors: tamalet c. J Med Virol. 2008 May;80(5):762-5. doi: 10.1002/jmv.21158. J Med Virol. 2008. PMID: 18360911

2

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).

Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group. Nordmann S, et al. J Viral Hepat. 2018 Feb;25(2):171-179. doi: 10.1111/jvh.12797. Epub 2017 Nov 20. J Viral Hepat. 2018. PMID: 28984055

3

Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in France.

Combes JD, Didelot JM, Radenne S, Zaegel-Faucher O, Lesage AC, Siproudhis L, Piroth L, Marchand L, Heard I, Hoyeau N, Henno S, Darragh TM, Alberts CJ, Clifford GM, Etienney I; ANRS-EP57-APACHES Study group. Combes JD, et al. J Infect Dis. 2024 Jul 25;230(1):55-60. doi: 10.1093/infdis/jiad506. J Infect Dis. 2024. PMID: 39052708

4

Transient CD4 cell recovery after hepatitis C virus cure in HIV/hepatitis C virus coinfected patients (ANRS CO13 HEPAVIH cohort).

Barré T, Ramier C, Ory K, Sogni P, Aumaitre H, Saidi T, Carrieri P, Marcellin F; ANRS CO13 HEPAVIH Study Group. Barré T, et al. HIV Med. 2024 Dec 11. doi: 10.1111/hiv.13752. Online ahead of print. HIV Med. 2024. PMID: 39663177 No abstract available.

5

Retraction Note: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection.

Colson P, Dhiver C, Tamalet C, Delerce J, Glazunova OO, Gaudin M, Levasseur A, Raoult D. Colson P, et al. Among authors: tamalet c. Sci Rep. 2024 May 1;14(1):9989. doi: 10.1038/s41598-024-60734-y. Sci Rep. 2024. PMID: 38693168 Free PMC article. No abstract available.

6

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH).

Barré T, Zucman D, Marcellin F, Ramier C, Protopopescu C, Tardieu R, Ory K, Salmon-Céron D, Carrieri P; ANRS CO13 HEPAVIH Study Group. Barré T, et al. J Viral Hepat. 2023 Nov;30(11):897-900. doi: 10.1111/jvh.13865. Epub 2023 Jun 26. J Viral Hepat. 2023. PMID: 37357886 No abstract available.

7

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH).

Marcellin F, Brégigeon-Ronot S, Ramier C, Protopopescu C, Gilbert C, Di Beo V, Duvivier C, Bureau-Stoltmann M, Rosenthal E, Wittkop L, Salmon-Céron D, Carrieri P, Sogni P, Barré T; ANRS CO13 HEPAVIH Study Group; Scientific Committee; Clinical Centers (ward: participating physicians); Data collection; Management, statistical analyses. Marcellin F, et al. JHEP Rep. 2022 Oct 28;5(1):100614. doi: 10.1016/j.jhepr.2022.100614. eCollection 2023 Jan. JHEP Rep. 2022. PMID: 36466990 Free PMC article.

8

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).

Barré T, Mercié P, Lions C, Miailhes P, Zucman D, Aumaître H, Esterle L, Sogni P, Carrieri P, Salmon-Céron D, Marcellin F; ANRS CO13 HEPAVIH Study Group. Barré T, et al. AIDS Res Ther. 2022 Mar 15;19(1):15. doi: 10.1186/s12981-022-00440-9. AIDS Res Ther. 2022. PMID: 35292069 Free PMC article.

9

Post-HCV cure self-reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH).

Marcellin F, Di Beo V, Esterle L, Abgrall S, Pialoux G, Barré T, Wittkop L, Salmon-Ceron D, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group. Marcellin F, et al. J Viral Hepat. 2021 Nov;28(11):1665-1667. doi: 10.1111/jvh.13605. Epub 2021 Sep 16. J Viral Hepat. 2021. PMID: 34472662 No abstract available.

10

Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.

Chalouni M, Pol S, Sogni P, Fontaine H, Lacombe K, Lacombe JM, Esterle L, Dorival C, Bourlière M, Bani-Sadr F, de Ledinghen V, Zucman D, Larrey D, Salmon D, Carrat F, Wittkop L; ANRS CO13 HEPAVIH, ANRS CO22 HEPATHER Cohorts Study Groups; Martinez V. Chalouni M, et al. HIV Med. 2021 Nov;22(10):924-935. doi: 10.1111/hiv.13153. Epub 2021 Aug 17. HIV Med. 2021. PMID: 34402547 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters